| Clindamycin 2,4-Diphosphate |
磷酸克林霉素杂质 I |
1309048-48-3 |
| Dasatinib DiMeric IMpurity |
达沙替尼杂质 |
910297-61-9 |
| 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- |
硼替佐米杂质K |
886979-78-8 |
| 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- |
硼替佐米杂质K |
886979-81-3 |
| Olmesartan medoxomil impurity I |
奥美沙坦酯杂质I |
879562-26-2 |
| 4-Methoxy-2,3,5-trimethylpyride-N-oxide |
4-甲氧基-2,3,5-三甲基吡啶氮氧化物 |
86604-80-0 |
| 2-ThiophenecarboxaMide, 5-chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-Morpholinyl)phenyl]aMino]propyl]- |
利伐沙班杂质G |
721401-53-2 |
| 3-methyl -4,5-diphenyl-4,5-didydro-isoxazole |
3-甲基-4,5-二苯基异恶唑 |
75115-00-3 |
| p-Toluenesulfonamide |
对甲苯磺酰胺 |
70-55-3 |
| 5-Chloro-1-(4-piperidyl)-2-benzimidazolinone |
5-氯-1,3-二氢-1-(4-哌啶基)-2H-苯并咪唑-2-酮 |
53786-28-0 |
| Theophylline Impurity 1 |
多索茶碱杂质2 |
5614-53-9 |
| CYCLOPENTYL PHENYL KETONE |
苯基酮环戊酯 |
5422-88-8 |
| 1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- |
利伐沙班邻苯二甲酰亚胺杂质 |
446292-08-6 |
| 1,1,2-TRIETHOXYETHANE |
乙氧基乙醛二乙基乙缩醛 |
4819-77-6 |
| ALPHA-PHENYLCYCLOPENTANEACETIC ACID |
Α-苯基环戊基乙酸 |
3900-93-4 |
| N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米杂质2(SR异构体,EP杂质E) |
289472-78-2 |
| (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米杂质 |
289472-80-6 |
| N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米杂质M |
289472-81-7 |
| para-Hydroxy Atorvastatin CalciuM Salt |
4-羟基阿托伐他汀（钙盐） |
265989-44-4 |
| Lansoprazole N-Oxide |
2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基]亚硫酰基]苯并咪唑 |
213476-12-1 |
